Teva Pharmaceuticals $TEVA has shed over 50% of its value following its $6.1B impairment charge and 75% dividend slash in its latest quarterly report. Pros: - The company continues to expect double digit sales growth from its recent Actavis acquisition from Allergan $AGN. - Teva expects over 1,500 new drugs to launch in 2017, with over 900 drugs still pending...
fallen too much, bad news seems priced in, lets take a small sl bet on it. good RR.
GUD DOUBLE TOP PATTERN BREAKDOWN: 9.801 TARGET; 8.625 (-12%) EXPECT PULLBACK/RETEST OF 9.80 LEVELS. NEGATIVE MANSFIELD WMA 150 DECREASING
IF ADXS BREAKS ABOVE RESISTANCE ON STRONG VOLUME- GO LONG IF IT HITS BOTTOM SUPPORT AND BOUNCES ON STRONG VOLUME- GO LONG
To continue higher PRGO will have to break above the top of the channel and the 200 MA line. Bears can look for bearish reversal signs inside this resistance zone.
The candles breached the lower bollie yesterday by more than 50% signaling a 85% likelyhood for a correction with the MACD and STO supporting my idea.
The $TEVA chart just keeps getting better and better.... Quarterly chart is rejecting last 2 major lows with a pinbar with stoch RSI overbought Ideally we bounce here to retest the fibs and form a right shoulder before complete capitulation. If the H&S formation is confirmed $TEVA should head down to levels we haven't seen since the 90's ($10 and below)
entry 4.00, exit 5.00 looks oversold, the study results were luke warm, but positive.
Regeneron is in a Trading - Range since nearly 1 year. I estimate a bounce.
We appear to be bottoming at the neckline of a potential H&S. This thing is a monster and can be easily seen on the 6 month and yearly time frames. You could buy the relief rally that takes us back up or wait for extra confirmation and sell the relief rally with a formation of that shoulder.
15/10/5 minute charts show double top @ 0.024. Going to hold this one but could be an indicator that we are going down.
If you check the ideas I´ve posted, you can see the monthly GILD chart, were you can clearly see the stock is about to blow up and at a great entry price. Right here you can see how the stock made 3 resistance levels, a few weeks ago it validated the second resistance and it just did with the first one. Enter now or regret it later. Go big or go home.
I consider GILD to be a great investment because of various factors: Talking fundamentaly, the company has great numbers and a lot of room to expand. It's free cash flow is stunning and the company is way to big to be bought. Technicaly: As you can see, the MACD, RSI and Stochastic are in line, and ready to go up up up. P/E is at a beautiful 6.95. As you can see...
No position yet. Refer to chart:) If you have any thoughts about this company, please leave in the comments:)
12.5.2016- $KBIO currently trading at 4.25. Potential once they receive PRV (Priority Review Voucher) for Benznidazole possibility for trading at $5-6. Stock jumped about $1 due to the Letter to Stakeholders by Dr. Cameron Durrant. I expect this stock to rise. Disclosure: I am long $KBIO SEE MORE: globenewswire.com